Anixa Biosciences, Inc. (ANIX)
5.055
-0.16
(-3.16%)
USD |
NASDAQ |
Dec 09, 16:00
5.12
+0.06
(+1.29%)
After-Hours: 18:47
Anixa Biosciences Market Cap: 166.39M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Puma Biotechnology, Inc. | 278.66M |
| GT Biopharma, Inc. | 6.807M |
| ImmunityBio, Inc. | 2.182B |
| Lexeo Therapeutics, Inc. | 315.49M |
Market Cap Related Metrics
| Price to Book Value | 10.03 |
| Price | 5.055 |
| Earnings Yield | -6.82% |